Janardhan Srinivasan, MD
Interventional Cardiology · South Boston, VANPI 1598099376
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (40.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Angiodynamics, Inc. at 41.7% of the total. Reporting peaked in 2023 at $4,448 and has fallen 99.1% since, to $41 in 2024.
Across 110 payments — averaging $92.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$4K
- Abbott$3K
- Penumbra, Inc.$1K
- Boston Scientific$386
- Medtronic$228
- Johnson & Johnson$226
- plus $878 from 17 others
Across 3 payments — averaging $16,667 each. An ownership or investment interest held by the physician or an immediate family member.
- Vasorum USA Inc.$50K
What the payments were for
- Travel & lodging$2,61626%
- Food & beverage$3,41134%
- Education$120%
- Other$4,13941%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 6 | $4,242 |
| Abbott | 22 | $2,937 |
| Penumbra, Inc. | 4 | $1,280 |
| Boston Scientific | 8 | $386 |
| Medtronic(2 entities) | 5 | $228 |
| Johnson & Johnson | 31 | $226 |
| Cardiovascular Systems Inc. | 5 | $149 |
| Bard Peripheral Vascular, Inc. | 2 | $119 |
| Teleflex LLC | 1 | $106 |
| Amgen | 5 | $82 |
| Chiesi USA, Inc. | 4 | $77 |
| Biotronik Inc. | 1 | $70 |
| Novartis | 5 | $67 |
| W. L. Gore & Associates, Inc. | 1 | $40 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $27 |
| Cordis US CORP. | 2 | $26 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Terumo Medical Corporation | 1 | $15 |
| Bayer | 1 | $14 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$4,139
- Omnilink Elite vascular stent system$2,304
- Indigo$1,265
- Supera peripheral stent system$134
- TWIN-PASS$106
How this compares
$10,178 in reported general payments places this provider in the 70th percentile of 176 interventional cardiology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in South Boston
- Deepak TalrejaVirginia Beach$1.5M
- Rajiv TayalFredericksburg$984K
- Gansevoort DunningtonRichmond$440K
- Matthew SummersNorfolk$308K
- Noah JonesFalls Church$238K
- Michael GenVirginia Beach$207K
- Jeremy BockLeesburg$202K
- Wayne BatchelorFalls Church$196K
- Matthew SherwoodFalls Church$193K
- Jason FoerstRoanoke$175K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.